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ABSTRACT 
 
    Aryl hydrocarbon receptor nuclear translocator (ARNT) forms a heterodimer with aryl 
hydrocarbon receptor or hypoxia inducible factor 1α to mediate biological responses to 
xenobiotic exposure and hypoxia. Although the regulation mechanism of the ARNT 
expression is largely unknown, earlier studies reported that the human ARNT protein level 
was decreased by hydrogen peroxide or reactive oxygen species. These stimuli increase the 
miR-24 level in various human cell lines. In silico analysis predicts that some microRNAs 
including miR-16 and miR-23b may bind to ARNT mRNA. This background prompted us to 
investigate whether human ARNT is regulated by microRNAs. Overexpression of miR-24 
into HuH-7 and HepG2 cells significantly decreased the ARNT protein level, but not the 
ARNT mRNA level, indicating translational repression. However, overexpression of miR-16 
or miR-23b caused no change in the ARNT expression. The miR-24-dependent 
down-regulation of ARNT decreased the expression of its downstream genes such as 
CYP1A1 and carbonic anhydrase IX.  Luciferase assay was performed to determine the 
element on the ARNT mRNA to which miR-24 binds. Finally, it was demonstrated that the 
miR-24 levels in a panel of 26 human livers were inversely correlated with the protein levels 
or the translational efficiency of ARNT. Taken together, we found that miR-24 negatively 
regulates ARNT expression in human liver, affecting the expression of its downstream genes. 
miR-24 would be one of the factors underlying the mechanisms by which ARNT protein is 
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Introduction 
 
     MicroRNAs (miRNAs), an evolutionarily conserved class of endogenous ~22-nucleotide 
noncoding RNAs, bind to target mRNAs causing translational repression or mRNA 
degradation (Bartel et al., 2004). In animals, miRNA target sites are located mainly in the 
3’-untranslated region (3’-UTR) of target mRNAs (Chekulaeva and Filipowicz, 2009), 
although there are examples of target sites in the coding region (Qin et al., 2010). Until now, 
over 1400 miRNAs have been identified in humans. One miRNA has the potential to target a 
large number (on average about 500) of genes. It has been estimated that 60% of human 
mRNAs could be targets of miRNAs (Betel et al., 2008; Friedman et al., 2009). However, the 
miRNA:mRNA pairs largely remain to be identified. Recently, we reported that miRNAs 
were involved in the regulation of human xenobiotics-metabolizing enzymes such as CYP1B1 
(Tsuchiya et al., 2006) and CYP2E1 (Mohri et al., 2010) and human nuclear receptors such as 
pregnane X receptor (Takagi et al., 2008), vitamin D receptor (Mohri et al., 2009), and 
hepatocyte nuclear factor 4α (Takagi et al., 2010). As a sequel study, we focused on human 
aryl hydrocarbon receptor nuclear translocator (ARNT).  
     ARNT, which is known as hypoxia-inducible factor 1β (HIF1β), is a member of the basic 
helix-loop-helix Per-ARNT-Sim (bHLH-PAS) family of transcription factors. It is 
ubiquitously and constitutively expressed in human tissues (Gradin et al., 1996), and the 
levels are particularly high in ovary, lung, spleen, testis and pancreas (Yamamoto et al., 2004). 
ARNT forms heterodimers with other bHLH-PAS proteins including aryl hydrocarbon 
receptor (AhR) and HIF1α. In response to xenobiotics, the heterodimer of ARNT/AhR binds 
to xenobiotic response element of the target genes such as cytochrome P450 and 
UDP-glucuronosyltransferases, which are important enzymes for the detoxification or 
metabolic activation, to increase their expression (Köhle  and Bock, 2007; Ramadoss et al., 
2005). In addition, under a hypoxia condition, ARNT dimerizes with HIF1α to upregulate the 
expression of genes involved in angiogenesis and tumorigenesis (Ke and Costa, 2006). 
Furthermore, ARNT homodimer binds to palindromic enhancer box (E-box) sequence to 
upregulate the expression of some genes such as mouse Cyp2a5 (Arpiainen et al., 2007). In 
the human genome, more than 13,000 putative ARNT binding sites have been estimated to 
exist by in silico analysis (Gunton et al., 2005). Collectively, ARNT regulates the expression 
of a vast number of genes. 
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    Despite the physiological importance of ARNT, it is largely unknown how the human 
ARNT expression is regulated. Earlier studies reported that the ARNT protein level was 
decreased by hydrogen peroxide (H2O2) or reactive oxygen species (ROS) in human cell lines 
(Choi et al., 2006, 2008), although the underlying molecular mechanism remains to be 
clarified.  In our previous study, it was demonstrated that the treatment of cells with H2O2 
increased the level of miR-24 (Takagi et al., 2010), which was supported by the finding that 
the ROS generation by hemin (Lal et al., 2009b) or arsenic trioxide (Meng et al., 2011) 
resulted in an increase of the miR-24 level. In this study, we investigated the possibility that 
the human ARNT expression might be regulated by miR-24. In addition, two other miRNAs, 
miR-16 and miR-23b, which were predicted by in silico analysis, were also investigated.  
  
Materials and Methods 
 
Chemicals and reagents. 3-Methylcholanthrene (3-MC) was obtained from Wako Pure 
Chemicals (Osaka, Japan). Deferoxamine mesylate (DFOM) was purchased from 
Sigma-Aldrich (St. Louis, MO). The pGL3-promoter (pGL3p) vector, phRL-TK and 
Dual-Luciferase Reporter Assay System were purchased from Promega (Madison, WI). 
Pre-miR miRNA Precursor Molecules for miR-24, miR-16, miR-23b and Negative Control #1 
(Control) were from Ambion (Austin, TX). Lipofectamine RNAiMAX, Stealth Select RNAi 
for human ARNT (HSS100700) (siARNT) and Negative Control Medium GC Duplex #2 
(siControl) were from Invitrogen (Carlsbad, CA). RNAiso, random hexamer, and SYBR 
Premix Ex Taq were from Takara (Shiga, Japan). ROX was purchased from Stratagene (La 
Jolla, CA). ReverTra Ace was obtained from Toyobo (Osaka, Japan). All primers were 
commercially synthesized at Hokkaido System Sciences (Sapporo, Japan). Goat anti-human 
ARNT polyclonal antibodies (N-19), rabbit anti-human AhR polyclonal antibodies (H-211) 
and rabbit anti-human HIF1α polyclonal antibodies (H-206) were from Santa Cruz 
Biotechnology (Santa Cruz, CA). Rabbit anti-human GAPDH polyclonal antibodies and 
rabbit anti-human β-actin polyclonal antibodies were from IMGENEX (San Diego, CA) and 
BioVision (Mountain view, CA), respectively. Alexa Fluor 680 donkey anti-goat IgG was 
from Invitrogen. IRDye 680 goat anti-rabbit IgG was from LI-COR Biosciences (Lincoln, 
NE). All other chemicals and solvents were of the highest grade commercially available. 
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Human liver samples and preparation of homogenates and total RNA. Human liver samples 
from 16 donors were supplied by National Disease Research Interchange (Philadelphia, PA) 
through the Human and Animal Bridging Research Organization (Chiba, Japan) and those 
from 10 donors were obtained from autopsy materials that were discarded after pathological 
investigation in Iwate Medical University (Morioka, Japan). The use of the human livers was 
approved by the Ethics Committees of Kanazawa University (Kanazawa, Japan) and Iwate 
Medical University. Total cell homogenates were prepared by homogenization with lysis 
buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40) 
containing protease inhibitors (0.5 mM (p-amidinophenyl) methanesulfonyl fluoride, 2 μg/ml 
aprotinin, 2 μg/ml leupeptin). The protein concentration was determined using Bradford 
protein assay reagent (Bio-Rad, Hercules, CA) with γ-globulin as a standard. Total RNA was 
prepared using RNAiso according to the manufacturer’s protocols and the integrity was 
assessed by estimating the ratio of the band density of 28S and 18S rRNA. 
 
Cell culture. Human hepatocellular carcinoma cell lines HuH-7 and HepG2 were obtained 
from Riken Gene Bank (Tsukuba, Japan). HuH-7 cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% 
fetal bovine serum (FBS) (Invitrogen). HepG2 cells were cultured in DMEM supplemented 
with 0.1 mM non-essential amino acid (Invitrogen) and 10% FBS. These cells were 
maintained at 37°C under an atmosphere of 5% CO2-95% air.  
 
Transfection of pre-miRNAs or siRNA and preparation of cell homogenates and total RNA. 
The HuH-7 or HepG2 cells were seeded into 6-well plates and transfected with 50 nM 
pre-miRNA or 20 nM siRNA using Lipofectamine RNAiMAX. After 72 hr, the cells were 
harvested and suspended in a small amount of TGE buffer [10 mM Tris-HCl, 20% glycerol, 1 
mM EDTA (pH 7.4)], disrupted by freeze-thawing three times and homogenized. Total RNA 
was also prepared as described above. In some cases, the cells were treated with 10 μM 3-MC 
(or 0.1% DMSO) for 24 hr or 200 μM DFOM for 12 hr, and cell homogenate or total RNA 
were prepared.  
 
SDS-PAGE and Western blot analyses. The cell homogenates from the HuH-7 and HepG2 
cells (20-30 µg) or human liver samples (40 µg) were separated with 7.5% 
SDS-polyacrylamide gel electrophoresis and transferred to Immobilon-P transfer membrane 
(Millipore, Bedford, MA). The membranes were probed with goat anti-human ARNT, rabbit 
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anti-human AhR, rabbit anti-human HIF1α, rabbit anti-human GAPDH or rabbit anti-human 
β-actin polyclonal antibodies and the corresponding fluorescent dye-conjugated second 
antibodies. The band densities were quantified with Odyssey Infrared Imaging system 
(LI-COR Biosciences). The ARNT and AhR protein levels were normalized with the GAPDH 
or β-actin protein levels. 
 
Real-time RT-PCR for ARNT and its downstream genes.  The cDNAs were synthesized from 
total RNA using ReverTra Ace. The sequences of the primers are shown in Table 1. A 1-µl 
portion of the reverse-transcribed mixture was added to a PCR mixture containing 10 pmol of 
each primer, 12.5 µl of SYBR Premix Ex Taq solution and 75 nM ROX in a final volume of 
25 µl. The PCR conditions were as follows: after an initial denaturation at 95°C for 30 s, the 
amplification was performed by denaturation at 94°C for 4 s, annealing and extension at 60°C 
(ARNT) or 64°C (carbonic anhydrase IX (CA IX), GAPDH and β-actin) for 20 s for 40 
cycles. For CYP1A1, after an initial denaturation at 95°C for 1 min, the amplification was 
performed by denaturation at 94°C for 15 s, annealing at 60°C for 30 s and extension at 72°C 
for 30 s for 40 cycles. The real-time RT-PCR was performed using Mx3000P (Stratagene, La 
Jolla, CA) with the MxPro QPCR software. The ARNT and CYP1A1 mRNA levels were 
normalized with the GAPDH mRNA level, and the CA IX mRNA level was normalized with 
the β-actin mRNA level.  
 
Real-time RT-PCR for mature miR-24.  The expression levels of mature miR-24 were 
determined by using the TaqMan microRNA assay (Applied Biosystems, Foster City, CA). 
The cDNA templates were prepared with the TaqMan microRNA Reverse Transcription kit 
which utilized the stem-loop reverse primers according to the manufacturer’s protocols. After 
the reverse transcription reaction, the product was mixed with TaqMan Universal PCR Master 
Mix and TaqMan MicroRNA assay containing the forward and reverse primers as well as the 
TaqMan probe for miR-24. The PCR condition was as follows: after an initial denaturation at 
95°C for 10 min, the amplification was performed by denaturation at 95°C for 15 s, annealing 
and extension at 60°C for 60 s for 40 cycles. The expression levels of U6 small nuclear RNA 
(U6 snRNA) were also determined by using the TaqMan microRNA assay and were used to 
normalize the miR-24 levels. 
 
Enzymatic activity. The enzymatic activity of CYP1A1 in HuH-7 cells was determined using 
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a P450-Glo Assay kit (Promega). After the transfection with pre-miRNA or siRNA, the cells 
seeded into 24-well plates were treated with 10 μM 3-MC (or 0.1% DMSO) for the last 24 hr, 
and then the medium was replaced with medium containing 50 μM Luciferin 6’-chloroethyl 
ether. After the incubation at 37°C for 8 hr under an atmosphere of 5% CO2-95% air, 100 μL 
of the medium were added to 100 μL of Luciferin Detection Reagent. After incubation for 20 
min at room temperature, the luminescence was measured with a luminometer (Wallac, Turku, 
Finland). The cells were resuspended in passive lysis buffer, and the protein concentrations 
were determined as described above. The enzymatic activity was normalized with the protein 
content.  
 
Construction of plasmids. The fragments +2933 to +3023, +3941 to +4118, and +844 to 
+1262 of the human ARNT mRNA were amplified by PCR and subcloned into the pGL3p 
vector at the Xba I site, downstream of the luciferase gene. These products were termed 
pGL3/MRE24_1, pGL3/MRE24_2, and pGL3/MRE24_3, respectively. A fragment 
containing the perfectly matching sequence with the mature miR-24, 5’- CTA GUG GCU 
CAG UUC AGC AGG AAC AG-3’ (the matching sequence of miR-24 is italicized), was also 
cloned (pGL3/c-24). DNA sequencing analyses confirmed the nucleotide sequences of these 
plasmids using Long-Read Tower DNA sequencer (GE Healthcare Bio-Sciences, Piscataway, 
NJ).  
 
Luciferase assay. Various pGL3 luciferase reporter plasmids were transiently transfected with 
phRL-TK plasmid into HepG2 cells. Briefly, the day before transfection, the cells were 
seeded into 24-well plates. After 24 hr, 190 ng of pGL3p plasmid, 10 ng of phRL-TK plasmid 
and 50 nM of Pre-miRNA were transfected into HepG2 cells using Tfx-20 reagent (Promega). 
After incubation for 48 hr, the cells were resuspended in passive lysis buffer, and then the 
luciferase activity was measured with a luminometer using the Dual-Luciferase Reporter 
Assay System.  
 
Statistical analysis. Statistical significance was determined by analysis of variance followed 
by Dunnett multiple comparisons test or Tukey method test. Comparison of two groups was 
made with an unpaired, two-tailed Student’s t test. Correlation analyses were performed by 
Spearman’s rank method. A value of P < 0.05 was considered statistically significant. 
 
Results 
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Effects of overexpression of miRNAs on ARNT expression in HuH-7 or HepG2 cells. 
 
When the precursor for miR-24 was transfected into HuH-7 cells, the ARNT protein 
level was significantly (P < 0.01) decreased (27% of control), but the ARNT mRNA level 
was not (Fig. 1A), indicating that the miR-24 negatively regulates the human ARNT 
expression through translational repression. Similar results (decreased 33% of control) were 
obtained with HepG2 cells (Fig. 1B). On this occasion, it was confirmed that the mature 
miR-24 level was significantly increased in both cell lines, although the extent in HuH7 cells 
was larger than that in HepG2 cells probably owing to the difference in transfection efficiency 
or processing of pre-miRNA to mature miRNA. The miR-24-dependent down-regulation of 
ARNT was also observed in colon carcinoma cell lines LS180 (40% of control) and breast 
adenocarcinoma cell lines MCF-7 (60% of control) (data not shown), suggesting that the 
phenomenon was common in the human cell lines.  
Next, we investigated whether other miRNAs might affect the ARNT expression. By a 
computational prediction using miRanda (http://www.microrna.org/microrna/home.do), 
PicTar (http://pictar.mdc-berlin.de/), and TargetScan (http://www.targetscan.org/), a number 
of miRNAs were predicted to bind to human ARNT. Among them, we chose miR-16 and 
miR-23b, because they are substantially expressed in human liver, and two out of three 
programs predicted them. When the precursor for miR-16 or miR-23b was transfected into 
HuH-7 or HepG2 cells, the ARNT protein level was not affected (Fig. 1C). Accordingly, it 
appeared that human ARNT is specifically regulated by miR-24. 
 
Effects of overexpression of miR-24 on induction of ARNT downstream genes. 
 
We investigated whether the miR-24-dependent down-regulation of ARNT might affect 
the induction of the downstream genes of ARNT. The treatment of HuH-7 cells with 3-MC, a 
potent ligand of AhR, significantly increased the CYP1A1 mRNA level (4.9-fold) (Fig. 2A). 
Interestingly, the induction was completely abrogated by the overexpression of miR-24. In 
addition, the overexpression of miR-24 significantly decreased the basal expression level of 
CYP1A1. It was confirmed that the ARNT protein was decreased by the overexpression of 
miR-24 in the presence of 3-MC (29% of control) (Fig. 2B), although the ARNT levels in the 
3-MC-treated cells were significantly lower than those in control cells. To investigate whether 
the decrease of CYP1A1 was due to the miR-24-dependent decrease of ARNT protein, we 
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performed a knocked down assay of ARNT. When the siARNT was transfected into HuH-7 
cells, the ARNT protein levels were decreased either in the absence or presence of 3-MC 
(38% and 40% of control, respectively) (Fig. 2B), which was similar to the result with 
miR-24. Under this condition, the induction of CYP1A1 was completely abrogated (Fig. 2A). 
Next, we investigated whether the miR-24 may affect the expression of AhR. It was 
demonstrated that the AhR protein level was also decreased by the overexpression of miR-24 
either in the absence or presence of 3-MC, and that the AhR protein levels in the 
3-MC-treated cells were significantly lower than those in control cells (Fig. 2C). The siARNT 
hardly affected the AhR protein levels. From these results, it was suggested that, although the 
decrease of AhR by miR-24 may also contribute, the miR-24-dependent down-regulation of 
ARNT would be a causal force of the repressed induction and the decreased basal expression 
of CYP1A1. Finally, we determined whether the CYP1A1 protein level was also affected. 
Since the CYP1A1 protein level in HuH-7 cells was too low to be detected by Western blot 
analysis, we evaluated the enzymatic activity of CYP1A1 using P450-Glo assay (Fig. 2D). 
The CYP1A1 activity was significantly (P < 0.001) increased by the treatment with 3-MC 
(3.1-fold), but the activity was diminished to under the detection limit by the overexpression 
of miR-24, and no induction by 3-MC was observed. In addition, the effects of siARNT on 
the CYP1A1 activity were similar to those of miR-24. These results suggest that the 
miR-24-dependent down-regulation of ARNT decreased the induction or basal expression of 
CYP1A1 protein. 
       We also investigated the effects of miR-24 on CYP1A1 mRNA expression in HepG2 
cells (Fig. 2E-G). Although the basal level of CYP1A1 mRNA in HepG2 cells was similar to 
that in HuH-7 cells (data not shown), the induction by 3-MC (23.1-fold) was more potent than 
that in HuH-7 cells. When the miR-24 was overexpressed, the expression levels of CYP1A1 
mRNA in the presence of 3-MC were significantly (P < 0.001) decreased, although the 
induction was still observed (Fig. 2E). This might be related to the fact that the ARNT protein 
level in HepG2 cells was ~2 fold higher than that in HuH-7 cells (Fig. 2F). Like in HuH-7 
cells, the ARNT protein levels in HepG2 cells were decreased by the overexpression of 
miR-24 either in the absence or presence of 3-MC. In addition, the ARNT protein levels were 
decreased by siARNT in the absence or presence of 3-MC (~40% of control), which was 
similar to the result with miR-24. The effects of siARNT on the CYP1A1 induction or 
expression were similar to those of miR-24. In contrast to HuH-7 cells, the AhR protein level 
in HepG2 cells was hardly decreased by 3-MC treatment, but that in the 3-MC-treated cells 
was decreased by overexpression of miR-24, whereas that in the control cells was increased 
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by overexpression of miR-24 (Fig. 2G). The siARNT hardly affected the AhR protein level 
like in the HuH-7 cells. These results suggest that the miR-24-dependent down-regulation of 
ARNT would be a determinant of the decreased the induction of CYP1A1 irrespective of the 
cell line.  
     Next, we investigated the effects of miR-24 on the expression of a target gene of HIF1α, 
another heterodimer partner of ARNT (Fig. 3A-C). When the HuH-7 cells were treated with 
DFOM, which is an inhibitor of the degradation of HIF1α that makes it accumulate like 
hypoxia, the CA IX mRNA level was significantly (P < 0.001) increased (4.0-fold) (Fig. 3A). 
When the miR-24 was overexpressed, the basal and DFOM-induced levels of CA IX mRNA 
were significantly decreased, although the induction was observed. It was confirmed that the 
ARNT protein was decreased by the overexpression of miR-24 in the presence of DFOM 
(32% of control) (Fig. 3B). When the siARNT was transfected into HuH-7 cells, the induction 
of CA IX by DFOM was repressed (Fig. 3A). We investigated whether the miR-24 may affect 
the expression of HIF1α protein. Although we did not quantify because of the interfering 
non-specific bands, we found no effect of miR-24 on the band density of HIF1α protein (Fig. 
3C). Thus, it was suggested that the miR-24-dependent down-regulation of ARNT decreased 
the expression and induction of the target genes of HIF1α. Since the CA IX mRNA level was 
not induced by DFOM in HepG2 cells (data not shown), we did not investigate further. 
 
Search of functional miRNA recognition element (MRE) in the ARNT mRNA. 
 
  We sought to identify the MRE for miR-24 (MRE24) in the ARNT mRNA. We used 
three programs, miRanda, PicTar, and TargetScans, to search possible elements in 3’-UTR 
based on complementarity to the seed sequence (nucleotides 2–8 at the 5’-end) of miRNA, 
free energy of the binding of miRNA to its target, or evolutionary conservation of MRE of the 
target gene. These programs did not raise MRE24, but raised the MRE for miR-16 and 
miR-23b (MRE16 and MRE23b). As shown in Fig. 4A, the predicted MRE16 and MRE23b 
showed a perfect match with the seed sequences. However, as described, the miR-16 or 
miR-23b did not function in the regulation of ARNT. Next, we sought to find the MRE24s 
using a software RNAhybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/), which 
calculates the free energy of the mRNA:miRNA hybrid without the restriction to 3’-UTR of 
the target gene. In the results, two MRE24s in the 3’-UTR and an MRE24 in the coding 
region of ARNT mRNA were predicted (Fig. 4A) and termed MRE24_1, MRE24_2, and 
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MRE24_3. Their free energies (-22.1 kcal/mol, -18.7 kcal/mol, and -28.6 kcal/mol, 
respectively) were comparable with those of MRE16 (-24.3 kcal/mol) or MRE23b (-16.6 
kcal/mol).  
To investigate whether these MRE24s are functional, luciferase assay using reporter 
plasmids containing a fragment including each MRE24 in 100 ~ 400-bp length was performed 
with HepG2 cells (Fig. 4B). When the pGL3/c-24 plasmid containing the miR-24 
complementary sequence downstream of the luciferase gene was transfected into the cells, the 
luciferase activity was significantly (P < 0.001) decreased by the co-transfection with the 
precursor for miR-24, suggesting that the overexpressed miR-24 was functional. When the 
pGL/MRE24_1, pGL/MRE24_2, or pGL/MRE24_3 plasmids were transfected, the luciferase 
activity was slightly decreased by the overexpression of miR-24, although the difference was 
statistically insignificant. Unfortunately, the luciferase assay could not identify the functional 
MRE for miR-24.  
 
Relationship between the expression levels of ARNT protein, ARNT mRNA, and miR-24 in 
human livers. 
 
To evaluate the significance of the miR-24-dependent regulation of the ARNT in human 
livers, we examined the relationship between the expression levels of ARNT protein, ARNT 
mRNA, and miR-24 using a panel of 26 human livers. The ARNT protein levels showing 
22-fold variability (except a sample No.24) (Fig. 5A) were not positively correlated with the 
ARNT mRNA levels (9-fold variability), indicating the involvement of post-transcriptional 
regulation (Fig. 5B). Interestingly, the miR-24 levels (25-fold variability) inversely correlated 
with the ARNT protein levels (r = -0.40, P < 0.05, Fig. 5C) as well as the translational 
efficiency calculated as the ratio of ARNT protein/mRNA (r = -0.38, P = 0.057, Fig. 5D). 





       ARNT mediates various biological actions such as hypoxia reaction, xenobiotic 
metabolism, teratogenesis, and immunosuppression through gene regulation by forming a 
heterodimeric complex with AhR, HIF1α and its homologous factors (HIF2α and HIF3α), or 
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with single minded homolog 2 (Liang et al., in press). A previous study (Maltepe et al., 1997) 
reported that systemic ARNT-null mice were embryonic lethal due to defects of angiogenesis 
and placental development, indicating the important role of ARNT in development. In spite of 
the indispensability of ARNT in mammals, it is largely unknown how the ARNT expression 
is regulated. In this study, we investigated the possibility that human ARNT might be 
regulated by miRNA. 
It was clearly demonstrated that the ARNT expression in human liver-derived cells is 
negatively regulated by miR-24. The miR-24-dependent down-regulation of ARNT affected 
the induction and expression of CYP1A1, a downstream gene of ARNT with a heterodimer 
partner AhR. As an unexpected result, we found that miR-24 decreased the AhR protein level. 
An MRE for miR-24 was predicted in the 3’-UTR of AhR by the TargetScan program 
supporting our result, although we did not investigate further. Thus, the decrease of AhR by 
miR-24 may also contribute, but the miR-24-dependent down-regulation of ARNT would be a 
determinant of the decrease of induction and expression of CYP1A1, since the effects of 
miR-24 and siARNT were similar. The AhR protein level was decreased by 3-MC treatment, 
in accordance with previous studies reporting the accelerated degradation through the 
ubiquitin-proteasome pathway after ligand binding (Davarinos and Pollenz, 2000; Ma and 
Baldwin, 2000). Although the mechanism of the decrease of ARNT by 3-MC treatment is 
unknown, we confirmed that it was not due to the increase of miR-24 level by 3-MC (data not 
shown). Anyway, the miR-24-dependent down-regulation of ARNT or AhR was irrespective 
of the presence of absence of ligand, the mechanism are independent of the mechanism of 
degradation by 3-MC. Next, we found that the miR-24-dependent down-regulation of ARNT 
affected the expression or induction of CA IX, a downstream gene of ARNT with a 
heterodimer partner HIF1α. Since the miR-24 did not affect the HIF1α protein, we can 
suggest that the change of CA IX expression was due to the decrease of ARNT. In contrast to 
CYP1A1, the effects of miR-24 and siARNT on the induction of CA IX were inconsistent. 
For this matter, it was speculated that miR-24 might be involved in another pathway(s) for 
CA IX induction that is independent of ARNT. Collectively, it was uncovered that the 
miR-24-dependent down-regulation of ARNT affects the expression or induction of its 
downstream genes whether the heterodimer is AhR or HIF1α. 
It has been reported that the ARNT protein level was decreased by H2O2 or ROS in human 
cell lines (Choi et al., 2006, 2008). In contrast, ARNT mRNA was not affected by these 
treatments (Choi et al., 2006), indicating the possibility of post-transcriptional regulation. 
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Previous evidence showed that ROS generated by H2O2 (Takagi et al., 2010), hemin (Lal et al., 
2009b) or arsenic trioxide (Meng et al., 2011) increased the miR-24 level in human cell lines. 
Since the present study uncovered the repression of ARNT by miR-24, it is suggested that the 
increase of the miR-24 by ROS and the decrease of ARNT by ROS could be causally related.  
The present study could not specify the MRE(s) on the ARNT mRNA that is functional in 
the miR-24-dependent regulation. It is possible that three predicted MRE24s showing faint 
down-regulation might function synergistically, because it has been reported that a 
combination of weak sites can effectively target an mRNA for silencing (Li et al., 2008). 
Another possibility is that the other unidentified MRE(s) might be functional. Although we 
searched MRE(s) based on the matching with the seed sequence, it is possible that the other 
seedless MRE(s) might be functional, because recent studies have shown that some miRNAs 
including miR-24 could regulate the target gene by recognizing seedless MREs (Lal et al., 
2009a, 2009b; Azzouzi et al., 2011). The identification of seedless MREs would be more 
difficult than canonical MREs. A luciferase assay using plasmids containing a sequential 
fragment of ARNT mRNA might be useful to identify the MREs, but we did not perform such 
an assay. Since we could not identify the functional MREs, one may surmise that the miR-24 
might indirectly affect the ARNT expression through down-regulation of some transcriptional 
factors. However, this possibility could be excluded, because the ARNT mRNA levels were 
not affected by the overexpression of miR-24 (Fig. 1A).  
During the process of preparing this report, an independent study reported that human 
ARNT in a colon carcinoma cell line HCT116 was down-regulated by miR-107 (Yamakuchi 
et al., 2010). It was reported that the miR-107-mediated regulation of ARNT affected the 
colon cancer tumor growth through the regulation of vascular endothelial growth factor, a 
target gene of HIF. The miR-107 was actually predicted to be a potential regulator of ARNT 
by in silico analysis, but we did not focus on miR-107 because the miRanda did not raise 
miR-107 as liver-enriched miRNAs. Supporting these data, we obtained by TaqMan 
MicroRNA Assay that miR-107 was not detectable in human hepatocytes (data not shown). 
However, it is known that miR-107 is overexpressed in various cancer tissues including colon, 
pancreas, stomach, and breast cancers (Volinia et al., 2006, Chen et al., 2011). Thus, the 
regulation of ARNT by miR-107 might be specific to cancer cells or tissues other than liver. 
By contrast, the miR-24 is the sixth most abundant miRNA in normal human liver. Thus, the 
regulation of ARNT in human liver by miR-24 would be very feasible. The inverse 
correlation between the ARNT protein and miR-24 levels in human liver samples supported 
the significance of the miR-24-dependent regulation of ARNT in liver (Fig. 5).  
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A previous study reported that miR-24 down-regulates E2F2 and Myc expression, playing 
a role in the inhibition of cell proliferation (Lal et al., 2009a). In addition, our previous study 
(Takagi et al., 2010) found that miR-24 down-regulated HNF4α in human liver, affecting bile 
acid synthesis. The present study could provide new evidence that miR-24 has 
pharmacological and toxicological relevance. 
In conclusion, we found that miR-24 negatively regulated the expression of human ARNT, 
affecting the expression of its downstream genes. Since miR-24 is under the control of 
cellular stress, elucidation of the regulation mechanism of the miR-24 expression would be 
valuable for understanding the change of ARNT expression in adaptation to environmental 
stimuli.  
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Figure legends 
 
Figure 1. Effects of overexpression of miRNAs on ARNT protein and mRNA level. (A, B) 
The ARNT protein levels in HuH-7 and HepG2 cells 72 hr after the transfection of precursors 
for miR-24 or negative control #1 (control) (50 nM) were determined by Western blot 
analysis and normalized with the GAPDH protein levels. The ARNT mRNA and miR-24 
levels were determined by real-time RT-PCR and normalized with the GAPDH mRNA and 
U6 snRNA levels, respectively. (C) The ARNT protein levels in HuH-7 and HepG2 cells 72 
hr after the transfection of precursors for miR-16 or miR-23b were also determined. The 
values represent the levels relative to no transfection (NT). Each column represents the mean 
± SD of three independent experiments. **P < 0.01. M: Marker. 
 
Figure 2. Effects of overexpression of miR-24 on the induction of CYP1A1. The precursors 
or siRNAs were transfected into HuH-7 and HepG2 cells. After 72 hr, the cells were treated 
with 10 μM 3-MC (or 0.1% DMSO for control) for 24 hr. (A, E) The CYP1A1 mRNA levels 
were determined by real-time RT-PCR and normalized with the GAPDH mRNA levels. The 
values represent the levels relative to that of control or siControl with DMSO treatment. (B, C, 
F, G) The ARNT and AhR protein levels were determined by Western blot analysis and 
normalized with the GAPDH protein levels. The values represent the levels relative to that of 
control or siControl of HuH-7 cells with DMSO treatment. *P < 0.05, **P < 0.01 and ***P < 
0.001, compared with DMSO treatment. #P<0.05, ##P<0.01 and ###P<0.001, compared with 
the precursor for control with DMSO treatment. †P < 0.05, ††P < 0.01 and †††P < 0.001, 
compared with the precursor for control with 3-MC treatment. M: Marker. (D) The enzymatic 
activities were determined by P450-Glo assay. ***P < 0.001, compared with DMSO 
treatment; ND: Not detected. Each column represents the mean ± SD of three independent 
experiments. 
 
Figure 3. Effects of overexpression of miR-24 on the induction of CA IX in HuH-7 cells. The 
precursors or siRNAs were transfected into HuH-7 cells. After 72 hr, the cells were treated 
with 200 μM DFOM for 12 hr. (A) The CA IX mRNA levels were determined by real-time 
RT-PCR and normalized with the β-actin mRNA levels.  (B, C) The ARNT and HIF1α 
protein levels were determined by Western blot analysis and normalized with the β-actin 
protein levels; M: Marker. ***P < 0.001, compared with vehicle. #P < 0.05 and ##P < 0.01, 
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compared with the precursor for control or siControl with vehicle. †P < 0.05, ††P < 0.01 and 
†††P < 0.001, compared with the precursor for control or siControl with DFOM treatment. The 
values represent the levels relative to that of control or siControl with vehicle. Each column 
represents the mean ± SD of three independent experiments.  
 
Figure 4. Luciferase assay using the plasmids containing the MRE24 in the 3’-UTR and 
coding region of human ARNT mRNA. (A) Schematic representation of human ARNT 
mRNA and the predicted target sequences of miR-24. The numbering refers to the 5’ end of 
mRNA as 1. MRE24_1 (from +2984 to +3007), and MRE24_2 (from +4012 to +4030) are 
located on the 3’-UTR of human ARNT mRNA (A). MRE24_3 (from +971 to +994) was 
located on the coding region of human ARNT mRNA. The predicted target sequences of 
miR-16 and miR-23b are shown in dotted line. Mfe, minimum free energy. Bold letters, seed 
sequence. The aglinment of each miRNA with the ARNT mRNA was drawn using 
RNAhybrid. (B) Luciferase assays using the reporter plasmids containing various fragments 
downstream of the firefly luciferase gene.  The reporter plasmids (190 ng) were transiently 
transfected with phRL-TK plasmid (10 ng) and 50 nM precursor or control into HepG2 cells. 
The firefly luciferase activity for each construct was normalized with the Renilla luciferase 
activities. Values are expressed as percentage of the relative luciferase activity of pGL3p 
plasmid. Each column represents the mean ± SD of three independent experiments. ***P < 
0.001. 
 
Figure 5. Relationship between the ARNT protein, ARNT mRNA, and miR-24 levels in 
human livers. (A) The ARNT protein levels in a panel of 26 human livers were determined by 
Western blot analysis and normalized with the GAPDH protein levels. The values represent 
the levels relative to that of the lowest sample among 25 detectable ones. M: Marker, ND: not 
detectable (B) Relationship between the ARNT mRNA and protein levels, (C, D) relationship 
between the miR-24 and ARNT protein levels or translational efficiency of ARNT (ARNT 
protein/mRNA ratio) in human livers. The expression levels of miR-24 and ARNT mRNA 
were determined by real-time RT-PCR and normalized with the U6 snRNA levels and 
GAPDH mRNA levels, respectively. The values represent the levels relative to that of the 








Table 1. Sequence of primers used for real-time RT-PCR analysis. 
Primer     Sequence     
ARNT forwarda 5' - GGAACAAGATGACAGCCTAC - 3' 
ARNT reversea 5' - CAGAAAGCCATCTGCTGCC - 3' 
CYP1A1 forwarda 5' - TCTTTCTCTTCCTGGCTATC - 3' 
CYP1A1 reversea 5' - CTGTCTCTTCCCTTCACTCT - 3' 
CA IX forward 5' - CAGTTGCTGTCTCGCTTGGAAG - 3' 
CA IX reverse 5' - TCGCTCGGAAGTTCAGCTGTAG - 3' 
GAPDH forwardb 5' - CCAGGGCTGCTTTTAACTC - 3' 
GAPDH reverseb 5' - GCTCCCCCCTGCAAATGA - 3' 
β-actin forward 5' - TCACCCTGAAGTACCCCATC - 3' 
β-actin reverse 5' - GATAGCACAGCCTGGATAGC - 3' 
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